Literature DB >> 20395269

Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.

Andrea Zelmer1, Melissa J Martin2, Ozan Gundogdu2, George Birchenough1, Rebecca Lever1, Brendan W Wren2, J Paul Luzio3, Peter W Taylor1.   

Abstract

Many neurotropic strains of Escherichia coli cause potentially lethal bacteraemia and meningitis in newborn infants by virtue of their capacity to elaborate the protective polysialic acid (polySia) K1 capsule. Recombinant capsule depolymerase, endosialidase E (endoE), selectively removes polySia from the bacterial surface; when administered intraperitoneally to infected neonatal rats, the enzyme interrupts the transit of E. coli K1 from gut to brain via the blood circulation and prevents death from systemic infection. We now show that experimental E. coli K1 infection is accompanied by extensive modulation of host gene expression in the liver, spleen and brain tissues of neonatal rats. Bacterial invasion of the brain resulted in a threefold or greater upregulation of approximately 400 genes, a large number of which were associated with the induction of inflammation and the immune and stress responses: these included genes encoding C-X-C and C-C chemokines, lipocalins, cytokines, apolipoproteins and enzymes involved in the synthesis of low-molecular-mass inflammatory mediators. Administration of a single dose of endoE, 24 h after initiation of systemic infection, markedly reduced, but did not completely abrogate, these changes in gene expression, suggesting that attenuation of E. coli K1 virulence by removal of the polySia capsule may minimize the attendant inflammatory processes that contribute to poor outcome in these severe systemic infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395269      PMCID: PMC2923034          DOI: 10.1099/mic.0.036145-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  44 in total

Review 1.  Ubiquitylation in innate and adaptive immunity.

Authors:  Vijay G Bhoj; Zhijian J Chen
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

2.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

3.  Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase.

Authors:  Naseem Mushtaq; Maria B Redpath; J Paul Luzio; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

4.  Dynamics of Escherichia coli infection and meningitis in infant rats.

Authors:  R Bortolussi; P Ferrieri; L W Wannamaker
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

Authors:  K S Kim; H Itabashi; P Gemski; J Sadoff; R L Warren; A S Cross
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  Homozygosity and risk of childhood death due to invasive bacterial disease.

Authors:  Emily J Lyons; William Amos; James A Berkley; Isaiah Mwangi; Mohammed Shafi; Thomas N Williams; Charles R Newton; Norbert Peshu; Kevin Marsh; J Anthony G Scott; Adrian V S Hill
Journal:  BMC Med Genet       Date:  2009-06-12       Impact factor: 2.103

7.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.

Authors:  O Ramilo; X Sáez-Llorens; J Mertsola; H Jafari; K D Olsen; E J Hansen; M Yoshinaga; S Ohkawara; H Nariuchi; G H McCracken
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

8.  EXPERIMENTAL TYPE III PNEUMOCOCCUS PNEUMONIA IN MONKEYS : II. TREATMENT WITH AN ENZYME WHICH DECOMPOSES THE SPECIFIC CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III.

Authors:  T Francis; E E Terrell; R Dubos; O T Avery
Journal:  J Exp Med       Date:  1934-04-30       Impact factor: 14.307

9.  THE ACTION OF A SPECIFIC ENZYME UPON THE DERMAL INFECTION OF RABBITS WITH TYPE III PNEUMOCOCCUS.

Authors:  K Goodner; R Dubos; O T Avery
Journal:  J Exp Med       Date:  1932-02-29       Impact factor: 14.307

10.  THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.

Authors:  O T Avery; R Dubos
Journal:  J Exp Med       Date:  1931-06-30       Impact factor: 14.307

View more
  16 in total

Review 1.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic Escherichia coli.

Authors:  George M H Birchenough; Malin E V Johansson; Richard A Stabler; Fatma Dalgakiran; Gunnar C Hansson; Brendan W Wren; J Paul Luzio; Peter W Taylor
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

Review 3.  The past, present, and future of enzyme-based therapies.

Authors:  Jennifer N Hennigan; Michael D Lynch
Journal:  Drug Discov Today       Date:  2021-09-16       Impact factor: 7.851

4.  The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection.

Authors:  Alex J McCarthy; Patricia Martin; Emilie Cloup; Richard A Stabler; Eric Oswald; Peter W Taylor
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

Review 5.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

6.  Bioluminescent imaging reveals novel patterns of colonization and invasion in systemic Escherichia coli K1 experimental infection in the neonatal rat.

Authors:  Luci A Witcomb; James W Collins; Alex J McCarthy; Gadi Frankel; Peter W Taylor
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

Review 7.  Bacteriophages and phage-derived proteins--application approaches.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

8.  Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.

Authors:  Shruti Bansal; Kusum Harjai; Sanjay Chhibber
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

Review 9.  Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska; Anne-Sophie Delattre; Rob Lavigne
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

10.  Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Klebsiella pneumoniae Capsular Exopolysaccharides.

Authors:  George Blundell-Hunter; Mark C Enright; David Negus; Matthew J Dorman; Gemma E Beecham; Derek J Pickard; Phitchayapak Wintachai; Supayang P Voravuthikunchai; Nicholas R Thomson; Peter W Taylor
Journal:  Front Cell Infect Microbiol       Date:  2021-06-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.